Aim: To estimate graft function after kidney transplantation during active herpesviruses or superinfection Materials and methods. The study included 32 patients (men 21, women 11) with end-stage chronic kidney disease. The median age was 43 years.
View Article and Find Full Text PDFCarbonatites host some unique ore deposits, especially REE, and fractional crystallization might be a potentially powerful mechanism for control enrichment of carbonatitic magmas by these metals to economically significant levels. At present, data on distribution coefficients of REE during fractional crystallization of carbonatitic melts at volcanic conditions are extremely scarce. Here we present an experimental study of REE partitioning between carbonatitic melts and calcite in the system CaCO-NaCO with varying amounts of PO, F, Cl, SiO, SO at 650-900 °C and 100 MPa using cold-seal pressure vessels and LA-ICP-MS.
View Article and Find Full Text PDFIndications of allogeneic hematopoietic stem cell transplantation (allo-HSCT) in patients with primary myelofibrosis are intermediate-2 and high-risk group of DIPSS (Dynamic International Prognostic Scoring System), beginning of the disease in childhood. The other adverse factors affect engraftment and survival after allo-HSCT, example partialy matched donor. But the result of allo-HSCT from matched related donors and result of allo-HSCT from haploidentical donors are comparable.
View Article and Find Full Text PDFPrimary myelofibrosis is a myeloproliferative neoplasm that occurs de novo, characterized by clonal proliferation of stem cells, abnormal expression of cytokines, bone marrow fibrosis, hepatosplenomegaly as a result of extramedullary hematopoiesis, symptoms of tumor intoxication, cachexemia, peripheral blood leukoerythroblastosis, leukemic progression and low survival. Primary myelofibrosis is a chronic incurable disease. The aims of therapy: preventing progression, increasing overall survival, improving quality of life.
View Article and Find Full Text PDFMediastinal gray-zone lymphoma (MGZL, lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma) was declared as a separate entity in WHO classification of Tumors of Haematopoetic and Lymphoid Tissues in 2008 and 2017 years. Despite of similar pathomorphological characteristics between primary mediastinal B-cell lymphoma and Hodgkin lymphoma, clinical features and optimal therapeutic approach to MGZL are not clearly defined. Usually MGZL manifests with mediastinal lymphadenopathy, although extranodal lesions often occur (grey-zone lymphoma, GZL).
View Article and Find Full Text PDF